1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. California >
  6. GHO Capital Partners Acquires Eliquent Life Sciences

M&A Deal Summary

GHO Capital Partners Acquires Eliquent Life Sciences

On December 20, 2018, private equity firm GHO Capital Partners acquired business services company Eliquent Life Sciences

Acquisition Highlights
  • This is GHO Capital Partners’ 1st transaction in the Business Services sector.
  • This is GHO Capital Partners’ 3rd transaction in the United States.
  • This is GHO Capital Partners’ 1st transaction in California.

M&A Deal Summary
Date 2018-12-20
Target Eliquent Life Sciences
Sector Business Services
Buyer(s) GHO Capital Partners
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) BKD (Financial)
O'Melveny & Myers (Legal)

Target

Eliquent Life Sciences

San Francisco, California, United States
Eliquent Life Sciences is a provider of consulting services to a broad range of clients across the biotech, pharma and medtech sectors. Eliquent Life Sciences was founded in 2005 and is based in San Francisco, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

GHO Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 6.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.

DEAL STATS #
Overall 9 of 25
Sector: Business Services M&A 1 of 3
Type: Buyout (LBO, MBO, MBI) M&A Deals 4 of 6
State: California M&A 1 of 4
Country: United States M&A 3 of 12
Year: 2018 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-02 BioAgilytix

Durham, North Carolina, United States

BioAgilytix is a bioanalytical testing laboratory focused on large molecule bioanalysis for the pharmaceutical, biotechnology and agriculture industries. BioAgilytix Lab's mission is to provide outsourced analysis of biological samples that support the work of companies seeking regulatory approval of their biopharmaceutical and agricultural products. BioAgilytix was founded in 2008 and is based in Durham, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-12 Sterling Pharma Solutions

Northumberland, United Kingdom

Sterling Pharma Solutions is a provider of API development and manufacturing. Sterling delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle. Sterling Pharma Solutions is based in Northumberland, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal